Daily Consumption of Virgin Coconut Oil Increases High-Density Lipoprotein Cholesterol Levels in Healthy Volunteers: A Randomized Crossover Trial

Not to be followed until your doctor gets around to writing up a diet protocol. Probably decades after you are dead.  

Daily Consumption of Virgin Coconut Oil Increases High-Density Lipoprotein Cholesterol Levels in Healthy Volunteers: A Randomized Crossover Trial

 Surarong Chinwong,1 Dujrudee Chinwong,1 and Ampica Mangklabruks2
1Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200,Thailand
2Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200,Thailand
Correspondence should be addressed to Dujrudee Chinwong; dujrudee.c@cmu.ac.th
Received 20 July 2017; Revised 31 October 2017; Accepted 16 November 2017; Published 14 December 2017
Academic Editor: Norman Temple
Copyright © 2017 Surarong Chinwong et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
This open-label, randomized, controlled, crossover trial assessed the effect of daily virgin coconut oil (VCO) consumption on plasma lipoproteins levels and adverse events.The study population was 35 healthy Thai volunteers, aged 18–25. At entry, participants were randomly allocated to receive either (i) 15mL VCO or (ii) 15mL 2% carboxymethylcellulose (CMC) solution (as control), twice
daily, for 8 weeks. After 8 weeks, participants had an 8-week washout period and then crossed over to take the alternative regimen for 8 weeks. Plasma lipoproteins levels were measured in participants at baseline, week-8, week-16, and week-24 follow-up visits.
Results. Of 32 volunteers with complete follow-up (16 males and 16 females), daily VCO intake significantly increased high-density lipoprotein cholesterol by 5.72mg/dL (𝑝 = 0.001) compared to the control regimen. However, there was no difference in the change in total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels between the two regimens. Mild diarrhea
was reported by some volunteers when taking VCO, but no serious adverse events were reported. Conclusion. Daily consumption of 30mL VCO in young healthy adults significantly increased high-density lipoprotein cholesterol. No major safety issues of taking VCO daily for 8 weeks were reported.